Summary
On the basis of experience with a patient, the problems encountered in the inducement of a proper and timely nutritional therapy in the case of a rapidly advancing malignant disease are shown. The report addresses the issue of criteria for determining malnutrition as well as the difference between enteral nutrition and parenteral nutrition.
Zusammenfassung
Anhand eines Patientenbeispiels werden die Schwierigkeiten der richtigen und rechtzeitig eingeleiteten Ernährungstherapie bei rasch fortschreitender maligner Erkrankung dargelegt. Es wird auf die Kriterien der Mangelernährung sowie auf die Unterschiede zwischen enteraler und parenteraler Ernährung eingegangen.
Similar content being viewed by others
Literatur
Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer, 34: 503–509, 1998
DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med, 69: 491–497, 1980
Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancer? Br J Cancer, 90: 1905–1911, 2004
Karthaus M, Frieler F. Eating and drinking at the end of life. Nutritional support for cancer patients in palliative care. Wien Med Wochenschr, 154: 192–198, 2004
Guidelines: Leitlinie "Enterale Ernährung" der DGEM u. DGG, 2004 (pdf). http://www.dgem.de
Klein S, Koretz RL. Nutrition support in patients with cancer: What do the data really show? Nutr Clin Pract, 9: 91–100, 1994
Gauderer MWL, Ponsky JL, Izant RJ. Gastrostomy without laparotomy. A percutaneous endoscopic technique. J Paediatr Surg, 15: 872–875, 1980
Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN, 11: 8–13, 1987
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weimann, P., Karthaus, M. Ernährungstherapie bei rasch progredienter maligner Erkrankung. Wien Med Wochenschr 160, 81–84 (2010). https://doi.org/10.1007/s10354-010-0755-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-010-0755-8